Pseudoangiomatous Stromal Hyperplasia (PASH) of the Breast: An Uncommon Finding in an Uncommon Patient

Am J Case Rep. 2020 Jan 16:21:e919856. doi: 10.12659/AJCR.919856.

Abstract

BACKGROUND Pseudoangiomatous stromal hyperplasia (PASH) is an uncommon benign breast lesion. CASE REPORT PASH is reported in a young female in treatment for neurological diseases with multi-drug therapy (clonazepam, valproate and risperidone). Her menstrual cycles are irregular, and she reached menarche very late. CONCLUSIONS The higher PASH prevalence in premenopausal woman (the majority of whom are actively taking oral contraceptive pills), in 24% to 47% of men with gynecomastia and during pregnancy supports a hormonal etiology; the interaction between clonazepam, valproate, risperidone and progesterone could increase the level of progesterone that could stimulate PASH growth.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Angiomatosis / diagnosis*
  • Angiomatosis / etiology
  • Angiomatosis / surgery
  • Biopsy, Large-Core Needle
  • Breast / cytology
  • Breast / pathology*
  • Breast Diseases / diagnosis*
  • Breast Diseases / etiology
  • Breast Diseases / surgery
  • Drug Interactions
  • Female
  • Humans
  • Hyperplasia / diagnosis*
  • Hyperplasia / etiology
  • Hyperplasia / surgery
  • Mastectomy, Segmental
  • Progesterone / metabolism
  • Stromal Cells / pathology*

Substances

  • Progesterone

Supplementary concepts

  • Pseudoangiomatous stromal hyperplasia